Skip to main content
Log in

Phase I-trial of clebopride, a new antiemetic, in chemotherapy — induced nausea and vomiting

  • Letters To The Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Barnes JH (1984) The physiology and pharmacology of emesis. Mol Aspects Med 7: 397–508

    CAS  PubMed  Google Scholar 

  2. Gralla RJ, Itri LM, Pisko SE (1981) Antiemetic efficiacy of high dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. N Engl J Med 305: 905–909

    CAS  PubMed  Google Scholar 

  3. Nao Y, Matsuo Y, Mori H (1982) Clinical effect of clebopride malate in gastric ulcer: A multicenter double blind study to determine optimum dosage. Adult Dis 12: 145–157

    Google Scholar 

  4. Nao Y (1982) Evaluation of optimal dosage of clebopride malate in multicentral double blind study. Curr Ther Res 31 [Suppl 1S]: 69–73

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lenz, H.J., Schuler, U., Hicking, W. et al. Phase I-trial of clebopride, a new antiemetic, in chemotherapy — induced nausea and vomiting. Eur J Clin Pharmacol 38, 525 (1990). https://doi.org/10.1007/BF02336697

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02336697

Key words

Navigation